Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus VCN-12 at the 32nd Annual Congress of the European Society of Gene …

Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of action ...

Clostridium Difficile Infections Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Pfizer, Valneva, Glax…

Some of the key facts of the Clostridium Difficile Infections Market Report: ...
pharmaphorum

After FDA exit, Peter Marks pops up at Lilly

The former director of the FDA's Center for Biologics Evaluation and Research (CBER), Peter Marks, has joined Eli Lilly as ...
Everyday Health

Is Your Gel Manicure Toxic?

The European Union just banned a common gel polish ingredient because animal studies suggest a possible link to infertility. Here’s what experts want you to know. The European Union announced a ban on ...